|
TMPO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.629800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.259500E-03 |
| Normal-vs-Stage2 |
1.765860E-02 |
| Normal-vs-Stage3 |
9.153400E-01 |
| Normal-vs-Stage4 |
8.399600E-01 |
| Stage1-vs-Stage2 |
8.859400E-01 |
| Stage1-vs-Stage3 |
9.303800E-02 |
| Stage1-vs-Stage4 |
2.332200E-01 |
| Stage2-vs-Stage3 |
7.353600E-02 |
| Stage2-vs-Stage4 |
1.924400E-01 |
| Stage3-vs-Stage4 |
8.902800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.675800E-02 |
| Normal-vs-AfricanAmerican |
4.544300E-02 |
| Normal-vs-Asian |
4.105200E-01 |
| Caucasian-vs-AfricanAmerican |
9.540800E-01 |
| Caucasian-vs-Asian |
8.652400E-01 |
| AfricanAmerican-vs-Asian |
8.015400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.243100E-03 |
| Normal-vs-Female |
6.938000E-01 |
| Male-vs-Female |
5.384200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.706060E-02 |
| Normal-vs-Extreme_Weight |
4.183300E-04 |
| Normal-vs-Obese |
8.640400E-01 |
| Normal-vs-Extreme_Obese |
1.769450E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.998400E-01 |
| Normal_Weight-vs-Obese |
6.672400E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.625390E-01 |
| Extreme_Weight-vs-Obese |
1.793680E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.888020E-01 |
| Obese-vs-Extreme_Obese |
2.044700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.632200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.583220E-01 |
| Normal-vs-Age(61-80Yrs) |
7.302200E-03 |
| Normal-vs-Age(81-100Yrs) |
7.358400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.520620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.261700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.067540E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.024600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.547800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.557640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.740500E-03 |
| Normal-VS-Type2 PRCC |
7.577900E-02 |
| Normal-VS-KIRP CIMP |
2.329800E-01 |
| Normal-VS-Unclassified PRCC |
4.418000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.748800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.042400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.571600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.828300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.831800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.721500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.239050E-03 |
| Normal-vs-N1 |
4.656100E-02 |
| Normal-vs-N2 |
3.695800E-01 |
| N0-vs-N1 |
9.201800E-04 |
| N0-vs-N2 |
5.457800E-01 |
| N1-vs-N2 |
2.171600E-01 |
|
|
